Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Skeletal Dysplasias , Panel Massive Sequencing (NGS) 36 Genes Reference Laboratory Genetics Spain | 72 | 36 |
|
CHONDRODYSPLASIA PUNCTATA 2 (X-LINKED DOMINANT) (CONRADI-HÜNERMANN-HAPPLE SYND.) Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
X-Linked Chondrodysplasia Punctata Type 2, Sequencing EBP Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Chondrodysplasia punctata Panel CeGaT GmbH Germany | 6 | 8 |
|
Potentially lethal skeletal disorders Panel CeGaT GmbH Germany | 45 | 44 |
|
X-linked dominant chondrodysplasia punctata Bioarray Spain | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 543 | 178 |
|
Asper Biogene Asper Biogene LLC Estonia | 166 | 74 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
XLID (X-Linked Intellectual Disability) NGS Panel Fulgent Genetics United States | 162 | 117 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
MedGene Slovakia | 1 | 1 |
|
Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
Amsterdam UMC, Location AMC Laboratory Genetic Metabolic Diseases, LGMD Netherlands | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.